Minecraft Classic is available on the web for free through a supporting web browser. In this post, we explain how to play Classic Minecraft and what to expect. Minecraft despite being around for over ...

The getsockopt error is a network issue in Minecraft that is usually caused by firewall blocks, DNS problems, or an unstable internet connection. The quick fixes ...

Mojang recently released a brand new friends list feature for Minecraft Java Edition. Previously, only Bedrock Edition gave you the option to send friend requests and add friends to the game. This ...

To add friends in Minecraft Java Edition, you first need to download Minecraft 26.2 snapshot 7, since this feature first dropped in that snapshot. If you are reading this at a later date, the feature ...

Minecraft's Java Edition has long been the go-to for PC players, owing to how moddable it is in comparison to its Bedrock counterpart. However, getting a clean multiplayer experience has long ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

If you've ever wanted to integrate OpenAI's ChatGPT features into your Java programs, you'll be happy to learn that Spring AI has made the process easier than ever. And it's not just easier to connect ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...